Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -59.22%-650.97M | ---- | 45.88%-408.85M | ---- | 32.40%-755.44M | ---- | 40.03%-1.12B | ---- | -1,237.00%-1.86B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -7.28%-221K | ---- | 98.08%-206K | ---- | 35.15%-10.72M | ---- | 28.67%-16.53M | ---- | 45.48%-23.18M |
| Interest expense - adjustment | ---- | -6.37%189.93M | ---- | 84.45%202.85M | ---- | 68.15%109.97M | ---- | -49.14%65.4M | ---- | 36.97%128.58M |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | -75.11%7.08M | ---- | 11.00%28.46M | ---- | 529.67%25.64M |
| Impairment and provisions: | ---- | 107,379.14%375.48M | ---- | 77.38%-350K | ---- | -100.60%-1.55M | ---- | -68.75%256M | ---- | 795,562.14%819.33M |
| -Impairmen of inventory (reversal) | ---- | -101.03%-784K | ---- | 87.58%-390K | ---- | -118.59%-3.14M | ---- | -1,651.22%-1.44M | ---- | -110.39%-82K |
| -Impairment of trade receivables (reversal) | ---- | -47.62%22K | ---- | -97.36%42K | ---- | -90.36%1.59M | ---- | 1,821.27%16.51M | ---- | -26.35%-959K |
| -Other impairments and provisions | ---- | 18,812,050.00%376.24M | ---- | -300.00%-2K | ---- | -100.00%1K | ---- | -70.63%240.93M | ---- | 616,917.29%820.37M |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | 199.07%10.97M | ---- | 682.99%3.67M | ---- | 94.47%-629K |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | 199.07%10.97M | ---- | 682.99%3.67M | ---- | 94.47%-629K |
| Asset sale loss (gain): | ---- | -643.45%-64.99M | ---- | 18,018.18%11.96M | ---- | 100.70%66K | ---- | -16,835.71%-9.37M | ---- | -99.16%56K |
| -Loss (gain) from sale of subsidiary company | ---- | ---77.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 8.09%12.93M | ---- | 18,018.18%11.96M | ---- | 100.70%66K | ---- | -16,835.71%-9.37M | ---- | -99.16%56K |
| Depreciation and amortization: | ---- | -12.81%332.7M | ---- | -9.16%381.59M | ---- | -11.24%420.06M | ---- | -1.08%473.26M | ---- | 6.52%478.4M |
| -Depreciation | ---- | -14.24%267.57M | ---- | -10.04%311.99M | ---- | -7.91%346.81M | ---- | -1.34%376.6M | ---- | 5.08%381.71M |
| -Amortization of intangible assets | ---- | -63.85%364K | ---- | -89.17%1.01M | ---- | -67.69%9.3M | ---- | 2.28%28.79M | ---- | 17.00%28.15M |
| Unrealized exchange loss (gain) | ---- | -50.76%-398K | ---- | -103.27%-264K | ---- | -51.16%8.07M | ---- | 486.50%16.52M | ---- | -234.35%-4.27M |
| Special items | ---- | ---- | ---- | ---- | ---- | -938.35%-5.52M | ---- | 86.12%-532K | ---- | ---3.83M |
| Operating profit before the change of operating capital | ---- | -2.78%181.53M | ---- | 186.04%186.72M | ---- | 27.83%-217.02M | ---- | 32.18%-300.71M | ---- | -223.48%-443.41M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 710.99%3.03M | ---- | -93.91%373K | ---- | 17.95%6.13M | ---- | 1,116.16%5.19M | ---- | -71.53%427K |
| Accounts receivable (increase)decrease | ---- | 238.66%23.46M | ---- | -111.34%-16.92M | ---- | 827.84%149.18M | ---- | -115.00%-20.5M | ---- | 242.27%136.68M |
| Accounts payable increase (decrease) | ---- | -150.45%-24.63M | ---- | 134.98%48.81M | ---- | -457.79%-139.55M | ---- | 80.13%-25.02M | ---- | -384.75%-125.89M |
| Cash from business operations | ---- | -16.26%183.38M | ---- | 208.81%218.99M | ---- | 40.98%-201.26M | ---- | 21.09%-341.03M | ---- | -239.98%-432.19M |
| Other taxs | ---- | 67.26%-11.93M | ---- | 11.77%-36.45M | ---- | -1,124.90%-41.32M | ---- | 58.81%-3.37M | ---- | 60.87%-8.19M |
| Special items of business | -51.98%44.17M | ---- | -5.09%91.98M | ---- | 200.44%96.91M | ---- | 38.87%-96.49M | ---- | 40.25%-157.84M | ---- |
| Net cash from operations | -51.98%44.17M | -6.08%171.45M | -5.09%91.98M | 175.25%182.54M | 200.44%96.91M | 29.57%-242.58M | 38.87%-96.49M | 21.79%-344.4M | 40.25%-157.84M | -253.01%-440.38M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -64.60%40K | 4.90%214K | 61.43%113K | -98.10%204K | -99.13%70K | -35.15%10.72M | 0.79%8.05M | -37.78%16.53M | -44.21%7.98M | -41.19%26.57M |
| Loan receivable (increase) decrease | ---- | 83.33%-15.74M | 75.12%-15.74M | ---94.42M | ---63.28M | ---- | ---- | ---- | ---- | -177.19%-91.46M |
| Sale of fixed assets | -98.80%102K | 155.22%8M | 226.55%8.5M | 2,428.23%3.14M | 16,168.75%2.6M | -98.79%124K | -92.63%16K | 2,795.77%10.28M | --217K | -57.84%355K |
| Purchase of fixed assets | 53.63%-4.41M | 9.64%-14.75M | 17.64%-9.51M | 61.49%-16.32M | 74.57%-11.55M | 20.21%-42.39M | -20.59%-45.41M | 79.90%-53.13M | 79.81%-37.66M | 20.26%-264.33M |
| Selling intangible assets | ---- | --175.56M | --175.56M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---12.39M |
| Sale of subsidiaries | ---- | ---- | ---- | --78.15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | --197.37M | ---- | ---- | ---- | -200.00%-500M |
| Cash on investment | 46.25%-1.23M | 24.33%-2.73M | -580.90%-2.28M | 38.19%-3.61M | 84.95%-335K | 56.61%-5.84M | 74.59%-2.23M | 14.30%-13.45M | -68.80%-8.76M | 85.59%-15.7M |
| Net cash from investment operations | -103.51%-5.5M | 558.15%150.55M | 316.08%156.64M | -120.54%-32.86M | -83.17%-72.49M | 502.34%159.99M | -3.55%-39.58M | 95.36%-39.77M | 94.64%-38.22M | -1,177.43%-856.94M |
| Net cash before financing | -84.44%38.68M | 115.13%322M | 918.00%248.62M | 281.23%149.68M | 117.95%24.42M | 78.50%-82.59M | 30.60%-136.07M | 70.39%-384.17M | 79.92%-196.06M | -453.15%-1.3B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | -77.14%80M | -27.27%80M | -34.93%350M | -63.33%110M | 975.80%537.9M | --300M | 2.04%50M |
| Refund | 94.81%-8.3M | -137.55%-167.48M | -481.73%-159.98M | 66.90%-70.5M | ---27.5M | -102.86%-213M | ---- | -222.09%-105M | ---75M | 78.31%-32.6M |
| Interest paid - financing | 26.92%-59.14M | 9.29%-156.55M | -30.11%-80.92M | -77.29%-172.57M | -97.23%-62.19M | -68.38%-97.34M | -30.56%-31.53M | 57.18%-57.81M | 39.59%-24.15M | -54.94%-134.99M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 62.09%-20.93M |
| Net cash from financing operations | 71.83%-69.17M | -90.05%-330.42M | -1,247.06%-245.56M | -617.19%-173.86M | -125.19%-18.23M | -90.98%33.62M | -63.11%72.37M | 365.80%372.64M | 397.59%196.15M | 44.99%-140.2M |
| Effect of rate | 90.88%-105K | -3,428.00%-2.5M | -194.73%-1.15M | -97.98%75K | 139.80%1.22M | -80.29%3.72M | -351.63%-3.05M | 1,394.92%18.87M | 84.47%-676K | -124.89%-1.46M |
| Net Cash | -1,096.99%-30.5M | 65.20%-8.42M | -50.61%3.06M | 50.62%-24.18M | 109.72%6.19M | -324.82%-48.97M | -69,338.04%-63.7M | 99.20%-11.53M | 100.01%92K | -1,377.60%-1.44B |
| Begining period cash | -17.26%52.32M | -27.60%63.23M | -27.60%63.23M | -34.13%87.34M | -34.13%87.34M | 5.86%132.6M | 5.86%132.6M | -91.99%125.26M | -91.99%125.26M | 8.19%1.56B |
| Cash at the end | -66.66%21.72M | -17.26%52.32M | -31.25%65.14M | -27.60%63.23M | 43.90%94.75M | -34.13%87.34M | -47.19%65.84M | 5.86%132.6M | -75.90%124.67M | -91.99%125.26M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.